1. Home
  2. Africa

Generic AIDS drugs to expand treatment

A clinical trial has shown that combination generic AIDS drugs are as effective as brand-name drugs and could provide hope for cheaper medicines in developing countries, British medical weekly, The Lancet, reports.

Conducted in Cameroon by the French Institut de Recherche Pour le Developpement, the six-month study found that 80 percent of the 60 HIV-positive respondents had an undetectable viral load after six months of taking two combo-pills a day.

"The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources," researchers said.

The 3-in-one pill replicates the AIDS cocktail recommended by the World Health Organisation (WHO) since 2002.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join